These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 34013453)

  • 21. Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.
    Tiengrim S; Phiboonbanakit D; Thunyaharn S; Tantisiriwat W; Santiwatanakul S; Susaengrat W; Srisurat N; Malithong A; Srisangchan P; Thamlikitkul V
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S6-17. PubMed ID: 22574524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in Mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016).
    Carvalhaes CG; Huband MD; Reinhart HH; Flamm RK; Sader HS
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial activity of ceftobiprole and comparator agents when tested against gram-positive and -negative organisms collected across China (2016-2018).
    Dandan Y; Shi W; Yang Y; Yonggui Z; Zhu D; Yan G; Hu F
    BMC Microbiol; 2022 Nov; 22(1):282. PubMed ID: 36435810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011.
    Flamm RK; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):437-42. PubMed ID: 24582578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative activities of sitafloxacin against recent clinical isolates in hospitals across China.
    Wu S; Yang Y; Guo Y; Yin D; Zheng Y; Han R; Ding L; Zhu D; Hu F
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2271-2283. PubMed ID: 34013453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sitafloxacin: in bacterial infections.
    Keating GM
    Drugs; 2011 Apr; 71(6):731-44. PubMed ID: 21504249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sitafloxacin hydrate for bacterial infections.
    Anderson DL
    Drugs Today (Barc); 2008 Jul; 44(7):489-501. PubMed ID: 18806900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    Lascols C; Legrand P; Mérens A; Leclercq R; Armand-Lefevre L; Drugeon HB; Kitzis MD; Muller-Serieys C; Reverdy ME; Roussel-Delvallez M; Moubareck C; Lemire A; Miara A; Gjoklaj M; Soussy CJ
    Eur J Clin Microbiol Infect Dis; 2011 Apr; 30(4):475-82. PubMed ID: 21088861
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.